Oren Livnat
Stock Analyst at HC Wainwright & Co.
(4.7)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
PCRX Pacira BioSciences | Maintains: Strong Buy | 48 65 | 26.81 | 142.45% | 20 | Apr 8, 2025 | |
VRCA Verrica Pharmaceutic... | Reiterates: Neutral | n/a | n/a | n/a | 12 | Apr 8, 2025 | |
COLL Collegium Pharmaceut... | Reiterates: Buy | 50 50 | 38.55 | 29.7% | 10 | Mar 24, 2025 | |
TRVI Trevi Therapeutics | Reiterates: Buy | 13 13 | 9.64 | 29.67% | 7 | Mar 19, 2025 | |
ANIP ANI Pharmaceuticals | Reiterates: Buy | 94 94 | 97.62 | -3.71% | 13 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 20 20 | 7.96 | 151.26% | 9 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 200 217 | 128.75 | 68.54% | 17 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 7 8 | 7.67 | 4.3% | 11 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 21 21 | 15.48 | 35.66% | 16 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 73 73 | 50.98 | 43.19% | 9 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 3.24 | 270.37% | 1 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 3.37 | 256.08% | 2 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 13 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 8 8 | 5.42 | 38.38% | 6 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 | 1.51 | 694.7% | 9 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 6 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 7 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 10 | 5.81 | 72.12% | 4 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 24 17 | n/a | n/a | 6 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Aug 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 8 | 1.18 | 577.97% | 2 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 6 | 5.59 | 0.18% | 4 | Apr 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 4 5 | 5.59 | -19.5% | 5 | Jan 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 43 60 | 2.98 | 1896.64% | 5 | Aug 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 11 8 | n/a | n/a | 2 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 252 198 | n/a | n/a | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | n/a | n/a | 6 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 13 | n/a | n/a | 2 | Oct 15, 2018 |